Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: so the next quarter we will have 10mio $ till now

that only 3 mio whas earned without j3 payments for ptsc so  we took 13mio from j3 for what ever

13billion revenues cut that be for 1month 0.01%

Share
New Message
Please login to post a reply